355 related articles for article (PubMed ID: 32409274)
1. Roles of the kisspeptin/GPR54 system in pathomechanisms of atherosclerosis.
Watanabe T; Sato K
Nutr Metab Cardiovasc Dis; 2020 Jun; 30(6):889-895. PubMed ID: 32409274
[TBL] [Abstract][Full Text] [Related]
2. Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist.
Sato K; Shirai R; Hontani M; Shinooka R; Hasegawa A; Kichise T; Yamashita T; Yoshizawa H; Watanabe R; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411243
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of vasostatin-1 against atherogenesis.
Sato Y; Watanabe R; Uchiyama N; Ozawa N; Takahashi Y; Shirai R; Sato K; Mori Y; Matsuyama T; Ishibashi-Ueda H; Hirano T; Watanabe T
Clin Sci (Lond); 2018 Dec; 132(23):2493-2507. PubMed ID: 30401690
[TBL] [Abstract][Full Text] [Related]
4. Neopterin Counters Vascular Inflammation and Atherosclerosis.
Shirai R; Sato K; Yamashita T; Yamaguchi M; Okano T; Watanabe-Kominato K; Watanabe R; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29420219
[TBL] [Abstract][Full Text] [Related]
5. Lipocalin-2 exerts pro-atherosclerotic effects as evidenced by in vitro and in vivo experiments.
Shibata K; Sato K; Shirai R; Seki T; Okano T; Yamashita T; Koide A; Mitsuboshi M; Mori Y; Hirano T; Watanabe T
Heart Vessels; 2020 Jul; 35(7):1012-1024. PubMed ID: 31960147
[TBL] [Abstract][Full Text] [Related]
6. Anti-Atherogenic Effects of Vaspin on Human Aortic Smooth Muscle Cell/Macrophage Responses and Hyperlipidemic Mouse Plaque Phenotype.
Sato K; Shirai R; Yamaguchi M; Yamashita T; Shibata K; Okano T; Mori Y; Matsuyama TA; Ishibashi-Ueda H; Hirano T; Watanabe T
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29891806
[TBL] [Abstract][Full Text] [Related]
7. Novel phytopeptide osmotin mimics preventive effects of adiponectin on vascular inflammation and atherosclerosis.
Takahashi Y; Watanabe R; Sato Y; Ozawa N; Kojima M; Watanabe-Kominato K; Shirai R; Sato K; Hirano T; Watanabe T
Metabolism; 2018 Jun; 83():128-138. PubMed ID: 29410350
[TBL] [Abstract][Full Text] [Related]
8. Legumain Promotes Atherosclerotic Vascular Remodeling.
Ozawa N; Sato Y; Mori Y; Masuda H; Yamane M; Yamamoto Y; Shirai R; Watanabe R; Sato K; Mori Y; Hirano T; Watanabe T
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31060209
[TBL] [Abstract][Full Text] [Related]
9. Adropin Contributes to Anti-Atherosclerosis by Suppressing Monocyte-Endothelial Cell Adhesion and Smooth Muscle Cell Proliferation.
Sato K; Yamashita T; Shirai R; Shibata K; Okano T; Yamaguchi M; Mori Y; Hirano T; Watanabe T
Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29701665
[TBL] [Abstract][Full Text] [Related]
10. Facilitatory effects of fetuin-A on atherosclerosis.
Naito C; Hashimoto M; Watanabe K; Shirai R; Takahashi Y; Kojima M; Watanabe R; Sato K; Iso Y; Matsuyama TA; Suzuki H; Ishibashi-Ueda H; Watanabe T
Atherosclerosis; 2016 Mar; 246():344-51. PubMed ID: 26828753
[TBL] [Abstract][Full Text] [Related]
11. Catestatin Prevents Macrophage-Driven Atherosclerosis but Not Arterial Injury-Induced Neointimal Hyperplasia.
Kojima M; Ozawa N; Mori Y; Takahashi Y; Watanabe-Kominato K; Shirai R; Watanabe R; Sato K; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
Thromb Haemost; 2018 Jan; 118(1):182-194. PubMed ID: 29304538
[TBL] [Abstract][Full Text] [Related]
12. Stimulatory effects of cardiotrophin 1 on atherosclerosis.
Konii H; Sato K; Kikuchi S; Okiyama H; Watanabe R; Hasegawa A; Yamamoto K; Itoh F; Hirano T; Watanabe T
Hypertension; 2013 Nov; 62(5):942-50. PubMed ID: 24041953
[TBL] [Abstract][Full Text] [Related]
13. Emerging Roles of Tumor Necrosis Factor-Stimulated Gene-6 in the Pathophysiology and Treatment of Atherosclerosis.
Watanabe R; Sato Y; Ozawa N; Takahashi Y; Koba S; Watanabe T
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29401724
[TBL] [Abstract][Full Text] [Related]
14. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
[TBL] [Abstract][Full Text] [Related]
15. Counteractive effects of omentin-1 against atherogenesis†.
Watanabe K; Watanabe R; Konii H; Shirai R; Sato K; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
Cardiovasc Res; 2016 May; 110(1):118-28. PubMed ID: 26790473
[TBL] [Abstract][Full Text] [Related]
16. Vasoprotective effects of urocortin 1 against atherosclerosis in vitro and in vivo.
Hasegawa A; Sato K; Shirai R; Watanabe R; Yamamoto K; Watanabe K; Nohtomi K; Hirano T; Watanabe T
PLoS One; 2014; 9(12):e110866. PubMed ID: 25462164
[TBL] [Abstract][Full Text] [Related]
17. EphA2 Expression Regulates Inflammation and Fibroproliferative Remodeling in Atherosclerosis.
Finney AC; Funk SD; Green JM; Yurdagul A; Rana MA; Pistorius R; Henry M; Yurochko A; Pattillo CB; Traylor JG; Chen J; Woolard MD; Kevil CG; Orr AW
Circulation; 2017 Aug; 136(6):566-582. PubMed ID: 28487392
[TBL] [Abstract][Full Text] [Related]
18.
Okano T; Sato K; Shirai R; Seki T; Shibata K; Yamashita T; Koide A; Tezuka H; Mori Y; Hirano T; Watanabe T
Int J Endocrinol; 2020; 2020():4139093. PubMed ID: 32308678
[No Abstract] [Full Text] [Related]
19. Contrasting effects of stanniocalcin-related polypeptides on macrophage foam cell formation and vascular smooth muscle cell migration.
Yamamoto K; Tajima Y; Hasegawa A; Takahashi Y; Kojima M; Watanabe R; Sato K; Shichiri M; Watanabe T
Peptides; 2016 Aug; 82():120-127. PubMed ID: 27346255
[TBL] [Abstract][Full Text] [Related]
20. Neopterin derivatives - a novel therapeutic target rather than biomarker for atherosclerosis and related diseases.
Watanabe T
Vasa; 2021 Apr; 50(3):165-173. PubMed ID: 32924886
[No Abstract] [Full Text] [Related]
[Next] [New Search]
